{"id":8250,"date":"2020-08-17T13:26:08","date_gmt":"2020-08-17T17:26:08","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/warned-non-medical-covid-19-treatment-producers\/"},"modified":"2020-08-17T13:26:08","modified_gmt":"2020-08-17T17:26:08","slug":"uyarilmis-tibbi-olmayan-covid-19-tedavi-ureticileri","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/uyarilmis-tibbi-olmayan-covid-19-tedavi-ureticileri\/","title":{"rendered":"Uyar\u0131ld\u0131: T\u0131bbi Olmayan COVID-19 Tedavisi \u00dcreticileri"},"content":{"rendered":"<p>Federal Ticaret Komisyonu ve G\u0131da ve \u0130la\u00e7 \u0130daresi ge\u00e7ti\u011fimiz g\u00fcnlerde yedi \u015firkete belirli \u00fcr\u00fcnleri satmay\u0131 b\u0131rakmalar\u0131n\u0131 veya iddialar\u0131n\u0131 g\u00f6zden ge\u00e7irmelerini s\u00f6yledi.<\/p>\n<p>D\u00fczenleyiciler, N-Ergetics olarak i\u015f yapan Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC ve The Jim Baker Show&#039;a g\u00f6nderilen toplu bir mektupta, bu \u015firketlerin bu \u015firketlerin k\u0131rk sekiz saati oldu\u011funu s\u00f6ylediler. hakk\u0131ndaki iddialar\u0131n\u0131 g\u00f6zden ge\u00e7irmek veya geri almak <u><a href=\"https:\/\/www.expertinstitute.com\/resources\/insights\/covid-19-supplement-scams-to-look-out-for\/?utm_campaign=Newsletter-7.30.20&amp;utm_medium=email&amp;_hsmi=92293581&amp;_hsenc=p2ANqtz-83hWGk1Ch017y_O4cJxrRIn0NTbVMFIfFaX7vh0niaseXEmsTfXTP4i_B8AnSivJPjiSJB4oCjQLhhTuQykJawSz0Zbg&amp;utm_content=insights-title-covid-cure-fraud&amp;utm_source=email\" target=\"_blank\" rel=\"noopener\">kolloidal g\u00fcm\u00fc\u015f<\/a><\/u>, \u00fcreticilerinin ve sat\u0131c\u0131lar\u0131n\u0131n koronavir\u00fcs\u00fc iyile\u015ftirdi\u011fini veya hafifletti\u011fini iddia etti\u011fi bir besin takviyesi.<\/p>\n<p>FDA defalarca bu t\u00fcr iddialar\u0131n as\u0131ls\u0131z oldu\u011funu s\u00f6yledi.<\/p>\n<p>Tahminen 150 milyon Amerikal\u0131 diyet takviyeleri kullan\u0131yor ve bu insanlar\u0131n 23 milyon kadar\u0131 t\u0131bbi \u00fcr\u00fcnler yerine takviyeleri kullan\u0131yor.<\/p>\n<p>Ad\u0131 ge\u00e7en yedi \u015firketten N-Ergetics hari\u00e7 her biri iddialar\u0131n\u0131 revize etti ve kolloidal g\u00fcm\u00fc\u015f satmaya devam etti.<\/p>\n<h2>Aldat\u0131c\u0131 \u0130ddialar<\/h2>\n<p>Bir\u00e7ok \u00fcr\u00fcn, &quot;yeni&quot; veya &quot;geli\u015ftirilmi\u015f&quot; gibi genel performans veya kalite iddialar\u0131nda bulunur.<\/p>\n<p>Bu iddialar neredeyse anlams\u0131zd\u0131r. Farkl\u0131 bir renge sahip bir ak\u0131ll\u0131 telefon yenidir, kimyasal form\u00fcl\u00fc de\u011fi\u015ftirilmi\u015f bir kutu soda en az\u0131ndan baz\u0131lar\u0131n\u0131n g\u00f6z\u00fcnde iyile\u015ftirilmi\u015ftir vb.<\/p>\n<p>\u00c7o\u011fu mahkeme, bu t\u00fcr beyanlar\u0131 sat\u0131\u015f \u015fi\u015fmesi olarak reddeder. Dolay\u0131s\u0131yla, \u00fcr\u00fcn bu iddialar\u0131 kar\u015f\u0131layamazsa, risk al\u0131c\u0131ya aittir.<\/p>\n<p><u><a href=\"https:\/\/www.law.cornell.edu\/ucc\/2\/2-313\" target=\"_blank\" rel=\"noopener\">Belirli iddialar<\/a><\/u> farkl\u0131d\u0131r. Bir takviye veya ba\u015fka bir \u00fcr\u00fcn, koronavir\u00fcs\u00fc iyile\u015ftirdi\u011fini, kanseri iyile\u015ftirdi\u011fini, sa\u00e7 uzatt\u0131\u011f\u0131n\u0131 veya ba\u015fka bir \u015fey yapt\u0131\u011f\u0131n\u0131 iddia ediyorsa, bu beklentiyi kar\u015f\u0131lamal\u0131d\u0131r.<\/p>\n<p>&quot;Bu beyan FDA taraf\u0131ndan de\u011ferlendirilmemi\u015ftir&quot; gibi bir sorumluluk reddi beyan\u0131 genellikle etkisizdir.<\/p>\n<p>Bir \u00fcr\u00fcn, onay yoluyla a\u00e7\u0131k bir garantiyi yerine getiremezse, ma\u011fdur al\u0131c\u0131lar\u0131n genellikle \u00fc\u00e7 yasal se\u00e7ene\u011fi vard\u0131r:<\/p>\n<ul>\n<li>Genellikle mallar\u0131n maliyeti ile nakliye ve di\u011fer \u00fccretler olan ekonomik kay\u0131plar i\u00e7in tazminat almak,<\/li>\n<li>Ba\u015fka bir yerden benzer bir \u00fcr\u00fcn alarak zarar\u0131 kar\u015f\u0131lay\u0131n (herhangi bir maliyet fark\u0131ndan as\u0131l sat\u0131c\u0131 sorumludur) veya<\/li>\n<li>Spesifik bir performans veya replevin s\u0131ras\u0131 elde edin.<\/li>\n<\/ul>\n<p>Mallar benzersizse ve sorun \u00e7\u00f6z\u00fclebilirse, spesifik performans uygundur.<\/p>\n<p>Bu d\u00fczen, sat\u0131c\u0131y\u0131 \u00fcr\u00fcn\u00fc do\u011fru yapmaya zorlar.<\/p>\n<p>Replevin benzer bir eylemdir. Al\u0131c\u0131, kar\u015f\u0131layamayacak durumdaysa, tamam\u0131n\u0131 \u00f6dememi\u015f olsa bile, t\u00fcm mallar\u0131n m\u00fclkiyetini al\u0131r.<\/p>\n<p>Aldat\u0131c\u0131 talep davalar\u0131 genellikle toplu davalard\u0131r.<\/p>\n<p>\u00c7ok say\u0131da davac\u0131, iddialar\u0131n\u0131 tek bir davada birle\u015ftirir. Toplu davalar genellikle milyonlarca dolarl\u0131k zararla sonu\u00e7lan\u0131r.<\/p>\n<h2>Tehlikeli \u00dcr\u00fcnler<\/h2>\n<p>FTC aldat\u0131c\u0131 iddialar\u0131 d\u00fczenler ve FDA tehlikeli \u00fcr\u00fcnleri d\u00fczenler. Temel olarak \u00fc\u00e7 t\u00fcr \u00fcr\u00fcn kusuru vard\u0131r:<\/p>\n<ul>\n<li><strong>\u00dcretme<\/strong>: Baz\u0131 \u00fcr\u00fcnler \u00e7izim tahtas\u0131nda iyi g\u00f6r\u00fcn\u00fcr. Ancak montaj hatt\u0131n\u0131n sonuna geldiklerinde art\u0131k g\u00fcvensizdirler. Belki bir makine uygun \u015fekilde kalibre edilmemi\u015ftir veya belki de \u00fcretici g\u00fcvenilir olanlar\u0131n yerine ucuz bile\u015fenleri kullanm\u0131\u015ft\u0131r.<\/li>\n<li><strong>Tasar\u0131m<\/strong>: Bir \u00fcr\u00fcn\u00fc piyasaya s\u00fcrmek i\u00e7in acele eden tasar\u0131mc\u0131lar, genellikle \u00f6l\u00fcmc\u00fcl bir tasar\u0131m kusurunu g\u00f6zden ka\u00e7\u0131r\u0131rlar. Alternatif olarak, m\u00fchendisler bir kusuru kapatmak i\u00e7in bir yama kullan\u0131r ve yama veya h\u0131zl\u0131 d\u00fczeltme ba\u015far\u0131s\u0131z olur.<\/li>\n<li><strong>Pazarlama<\/strong>: Modern pazar ara\u015ft\u0131rmas\u0131, \u00fcr\u00fcn \u00fcreticilerinin pazarlama kampanyalar\u0131n\u0131 belirli ki\u015filere veya ki\u015fi gruplar\u0131na g\u00f6re uyarlamas\u0131na olanak tan\u0131r. Tide, CBS, Univision ve CNN&#039;de reklam yay\u0131nl\u0131yor, ancak reklamlar farkl\u0131 g\u00f6r\u00fcn\u00fcyor. Bu t\u00fcr faaliyetler yasald\u0131r. Ancak, hassas gruplara \u00fcr\u00fcn pazarlamak yasa d\u0131\u015f\u0131d\u0131r. \u0130la\u00e7 \u015firketleri, re\u00e7eteli a\u011fr\u0131 kesici reklamlar\u0131yla ba\u011f\u0131ml\u0131lar\u0131 iyile\u015ftirmeyi hedefleyemez.<\/li>\n<\/ul>\n<p>\u00dcreticiler, tehlikeli \u00fcr\u00fcnlerle ilgili yaralanmalardan kesinlikle sorumludur. Ma\u011fdur\/davac\u0131lar sadece sebebi ispatlamal\u0131d\u0131r.<\/p>\n<p>Tipik olarak, hakimler bu talepleri <u><a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/\">\u00c7ok B\u00f6lgeli Dava<\/a><\/u> mahkemeler. MDL bir \u015fekilde s\u0131n\u0131f eylemine benzer, ancak tam olarak de\u011fil.<\/p>\n<p>M\u00fcnferit davalar\u0131n ger\u00e7ekleri y\u00fczde 100 konsolidasyon i\u00e7in \u00e7ok farkl\u0131d\u0131r, ancak duru\u015fma \u00f6ncesi ama\u00e7lar i\u00e7in birle\u015ftirilebilirler.<\/p>\n<p>Genellikle, bir MDL hakimi, ke\u015fif ve di\u011fer \u00f6n duru\u015fma konular\u0131n\u0131 denetlemesi i\u00e7in y\u00fcksek nitelikli \u00f6zel bir usta atar.<\/p>\n<p>Bireysel dava \u00e7\u00f6z\u00fclmezse, genellikle yarg\u0131lama i\u00e7in kendi yarg\u0131 yetkisine geri d\u00f6ner.<\/p>\n<p>Aldat\u0131c\u0131 iddialar ve tehlikeli \u00fcr\u00fcnler genellikle ayn\u0131 anda milyonlarca ki\u015fiye zarar verir. ile \u00fccretsiz dan\u0131\u015fma i\u00e7in <u><a href=\"\/tr\/bize-ulasin\/\">New York&#039;ta deneyimli ki\u015fisel yaralanma avukat\u0131<\/a><\/u>, contact Napoli Shkolnik . We do not charge upfront legal fees.<\/p>","protected":false},"excerpt":{"rendered":"<p>Federal Ticaret Komisyonu ve G\u0131da ve \u0130la\u00e7 \u0130daresi ge\u00e7ti\u011fimiz g\u00fcnlerde yedi \u015firkete belirli \u00fcr\u00fcnleri satmay\u0131 b\u0131rakmalar\u0131n\u0131 veya iddialar\u0131n\u0131 g\u00f6zden ge\u00e7irmelerini s\u00f6yledi. Vital Silver&#039;a g\u00f6nderilen toplu bir mektupta,\u2026<\/p>","protected":false},"author":3,"featured_media":8251,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[820,875,877,895,917,918,919,927,972,978,816],"class_list":["post-8250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-product-liability","tag-bad-drugs","tag-drug-side-effects","tag-class-actions","tag-pharmaceutical-lawsuit","tag-pharmaceutical-lawyers","tag-pharmaceutical-injuries-lawyer-new-york","tag-class-action-lawyers","tag-fda-recall","tag-fda-warning","tag-defective-products"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8250"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8250\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8251"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}